USPTO Examiner SHI KATHERINE MENGLIN - Art Unit 3771

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18994905DISTAL PROTECTION DEVICE AND MANUFACTURING METHOD THEREFORJanuary 2025June 2025Allow500YesNo
18859162ASPIRATION APPARATUSES FOR CLOT REMOVALOctober 2024June 2025Allow810YesNo
18916474INTERVENTIONAL SYSTEMS AND ASSOCIATED DEVICES AND METHODSOctober 2024December 2024Allow200YesNo
18426389TRANSCATHETER HEART VALVE HAVING PARAVALVULAR LEAKAGE SEALJanuary 2024September 2024Allow800YesNo
18424344LATCH MECHANISM FOR PREVENTING LANCET OSCILLATION IN A LANCING DEVICEJanuary 2024February 2025Allow1310YesNo
18408054SURGICAL FASTENER DEPLOYMENT SYSTEMJanuary 2024June 2025Allow1721YesNo
18407835SYSTEMS AND METHODS FOR ENDOMETRIAL ABLATIONJanuary 2024September 2024Allow900YesNo
18568044Applicator for Robotic-Assisted SurgeryDecember 2023June 2025Allow1800YesNo
18520313LEFT ATRIAL APPENDAGE OCCLUSION DEVICENovember 2023March 2025Allow1611YesNo
18509894DELIVERY AND DETACHMENT SYSTEMS AND METHODS FOR VASCULAR IMPLANTSNovember 2023April 2025Allow1720YesNo
18498282SYSTEMS, METHODS, AND DEVICES FOR CLOSING HOLES IN BODY LUMENSOctober 2023April 2025Allow1711YesNo
18495660DEVICES, SYSTEMS AND METHODS FOR HEART VALVE REPLACEMENTOctober 2023April 2025Allow1720NoNo
18377264TRANSCATHETER HEART VALVE HAVING PARAVALVULAR LEAKAGE SEALOctober 2023December 2023Allow200YesNo
18476625KIDNEY STONE SUCTION DEVICESeptember 2023November 2024Allow1410NoNo
18461572Flavored Teething Device for InfantsSeptember 2023June 2025Allow2100YesNo
18448571APPARATUS AND METHOD FOR USE OF AN INCLINOMETER-AIDED NEEDLE GUIDEAugust 2023September 2024Allow1300YesNo
18230008Apparatus and Methods for Delivering Hemostatic Materials for Blood Vessel ClosureAugust 2023October 2024Allow1410YesNo
18226410TRANSSEPTAL ACCESS DEVICE AND METHOD OF USEJuly 2023February 2025Allow1910YesNo
18353616Ultrasonic Transducer Tissue SelectivityJuly 2023August 2024Allow1300YesNo
18351375MEDICAL DEVICE AND METHOD FOR PREVENTING ADHESIONSJuly 2023August 2024Allow1300YesNo
18346089LAPAROSCOPIC GRASPERS AND SYSTEMS THEREFORJune 2023August 2024Allow1300YesNo
18210674TRANSCATHETER HEART VALVE HAVING PARAVALVULAR LEAKAGE SEALJune 2023August 2023Allow200YesNo
18205685Oral Development Teething RingJune 2023April 2025Allow2300YesNo
18324017DEVICES, SYSTEMS, AND METHODS FOR TREATMENT OF INTRACRANIAL ANEURYSMSMay 2023October 2024Allow1610YesNo
18201504FLEXIBLE ENDOLUMINAL DEVICEMay 2023December 2024Allow1911NoNo
18314351FORCEPS INCLUDING A PRE-LOADED HANDLE LATCHMay 2023July 2024Allow1400YesNo
18142772DEVICE AND METHOD FOR ORIENTING A MEDICAL OBJECTMay 2023July 2023Allow200YesNo
18303734ADJUSTABLE SUTURE-BUTTON CONSTRUCT FOR ANKLE SYNDESMOSIS REPAIRApril 2023April 2025Allow2421YesNo
18180786GUIDED ADVANCEMENT OF AN IMPLANTMarch 2023January 2025Abandon2211NoNo
18113998KNOTLESS BONE ANCHOR SYSTEM AND METHODFebruary 2023June 2025Allow2810NoNo
18172806VALVULAR INSUFFICIENCY REPAIR DEVICE AND METHODFebruary 2023May 2025Allow2740NoNo
18166757TECHNIQUES FOR GUIDE-WIRE BASED ADVANCEMENT OF A TOOLFebruary 2023November 2024Allow2111YesNo
18153313EAR CANAL CLAMP FOR SMALL ANIMALSJanuary 2023March 2025Allow2600YesNo
18091986LATCH MECHANISM FOR PREVENTING LANCET OSCILLATION IN A LANCING DEVICEDecember 2022September 2023Allow820NoNo
18066989Occlusion SystemsDecember 2022January 2025Allow2511YesNo
18001981METHOD AND APPARATUS FOR MITRAL VALVE CHORD REPAIRDecember 2022March 2025Allow2700YesNo
18063510VALVULAR INSUFFICIENCY REPAIR DEVICE AND METHODDecember 2022April 2024Allow1600YesNo
18075356VAGINAL DILATORDecember 2022March 2025Allow2800NoNo
18058203Externally Applied Intrapartum Support DeviceNovember 2022October 2024Allow2220NoNo
18056199RETRIEVAL SYSTEMS AND METHODS FOR USE THEREOFNovember 2022April 2025Allow2930YesNo
17925511TISSUE CLIP APPLICATION FITTING OR RETROFITTING SETNovember 2022March 2025Allow2800YesNo
17998140DEVICES FOR ASSISTING NEUROSURGICAL INTERVENTIONSNovember 2022May 2025Allow3101YesNo
17980012ADJUNCT MATERIALS AND METHODS OF USING SAME IN SURGICAL METHODS FOR TISSUE SEALINGNovember 2022June 2024Allow4500YesNo
18052053HEMOSTASIS RELOADABLE CLIP RELEASE MECHANISMNovember 2022June 2024Allow1900NoNo
17969851INTRASACCULAR INVERTING BRAID WITH HIGHLY FLEXIBLE FILL MATERIALOctober 2022November 2024Abandon2510YesNo
17968878SKIN TREATMENT APPARATUS WITH COOLING MEMBEROctober 2022July 2024Allow2120NoNo
17938250HERNIA REPAIR GRAFTS HAVING ANTI-ADHESION BARRIERSOctober 2022April 2024Allow1800YesNo
17959222LAPAROSCOPIC FASCIAL CLOSURE SYSTEMOctober 2022March 2024Allow1700NoNo
17952765SLIDING SUTURE GRASPERSeptember 2022January 2025Allow2820YesNo
17952483FRAGMENTATION TIPSeptember 2022June 2025Abandon3310NoNo
17914504MEDICAL INSTRUMENT SUITABLE FOR LIGATURE OR SIMILARSeptember 2022March 2025Allow3010NoNo
17949103METHOD AND APPARATUS FOR MEASURING FLOW THROUGH A LUMENSeptember 2022April 2024Allow1900YesNo
17948402FORWARD-PUSHING FOR RELEASING SUTURE LOCKING DEVICESeptember 2022February 2025Allow2910NoNo
17932038Joining ElementSeptember 2022December 2024Allow2700YesNo
17931305EXCLUSION DEVICE COVERS AND RELATED METHODSSeptember 2022October 2024Allow2501YesNo
17941307METHODS AND DEVICES FOR INCREASING AQUEOUS DRAINAGE OF THE EYESeptember 2022January 2025Allow2901NoNo
17941411PACIFIER WITH CHEEK STABILIZERSSeptember 2022May 2025Abandon3210YesNo
17929432ENDOVASCULAR DEVICE CONFIGURED FOR SELECTIVE NARROWINGSeptember 2022August 2024Allow2310YesNo
17821975AUTOMATED METHOD OF REMOVING CLOG WITHIN LUMEN FOR DEBRIS REMOVALAugust 2022August 2024Allow2411YesNo
17819782HEART VALVE REPAIR USING SUTURE KNOTSAugust 2022October 2024Allow2721YesNo
17888196SURGICAL ACCESS ASSEMBLY AND METHOD OF USING SAMEAugust 2022April 2025Allow3230YesNo
17887440TISSUE SAMPLE AND SNARE DEVICEAugust 2022September 2024Allow2500YesNo
17886623TRANSSEPTAL ACCESS DEVICE AND METHOD OF USEAugust 2022March 2023Allow820YesNo
17817624PERCUTANEOUS LARGE HOLE PROCEDUREAugust 2022February 2023Allow600NoNo
17860004MEDICAL DEVICEJuly 2022September 2024Allow2600YesNo
17810182HOLDER AND DEPLOYMENT SYSTEM FOR PROSTHETIC HEART VALVESJune 2022February 2024Allow1900YesNo
17847856Occlusion DeviceJune 2022February 2024Allow1900YesNo
17841482Teething Pacifier RingJune 2022July 2023Allow1300YesNo
17756207DEVICE FOR TISSUE REMOVALMay 2022March 2025Allow3411YesNo
17748708Method and Apparatus for Skin ResurfacingMay 2022October 2024Allow2920YesNo
17741517LATCH MECHANISM FOR PREVENTING LANCET OSCILLATION IN A LANCING DEVICEMay 2022November 2022Allow610NoNo
17740002SUTURE CLIP AND SUTURE CLIP APPLIERMay 2022August 2024Allow2711YesNo
17737534VASCULAR PROSTHETIC DELIVERY DEVICE AND METHOD OF USEMay 2022January 2024Allow2100YesNo
17735711TRANSSEPTAL ACCESS DEVICE AND METHOD OF USEMay 2022September 2023Abandon1720YesYes
17773840DEVICES AND METHODS FOR APPLYING A HEMOSTASIS CLIP ASSEMBLYMay 2022May 2025Allow3611YesNo
17729816SUTURE BASED CLOSURE DEVICEApril 2022November 2024Allow3110YesNo
17694469APPARATUS AND METHODS FOR SEALING A VASCULAR PUNCTUREMarch 2022March 2024Allow2400YesNo
17641450REDUCTION IN DIAMETERMarch 2022December 2024Allow3311YesNo
17637886CANNULA DEVICEFebruary 2022December 2024Allow3410YesNo
17651543LEFT ATRIAL APPENDAGE TREATMENT SYSTEMS AND METHODSFebruary 2022February 2024Allow2400YesNo
17584733ALL-SUTURE ANCHOR AND DEPLOYMENT ASSEMBLYJanuary 2022January 2025Allow3610YesNo
17574019Cervical DilatorJanuary 2022May 2025Abandon4020NoNo
17565514KNOTLESS ANCHOR INSERTER TOOL EXTRACTIONDecember 2021July 2024Allow3020YesNo
17552001SUTURE THREADER FOR BONE PLATEDecember 2021February 2024Allow2600YesNo
17546386Adaptive Sutures Dynamically Changing Wound Holding Properties Post-ImplantationDecember 2021August 2024Allow3220NoNo
17542012Externally Applied Intrapartum Support DeviceDecember 2021July 2022Allow810YesNo
17538789DYNAMIC TENSIONING DEVICES FOR ORTHOPEDIC COMPRESSIONNovember 2021August 2024Allow3311YesNo
17456195ENDOVASCULAR DEVICE WITH DISTAL ELECTRODENovember 2021September 2022Allow1011NoNo
17456199ENDOVASCULAR DEVICE CONFIGURED FOR SELECTIVE NARROWINGNovember 2021May 2022Allow601YesNo
17522972KNOTLESS TENSIONABLE FIXATION SYSTEMS AND SURGICAL METHODS FOR REPAIRING TISSUE DEFECTSNovember 2021April 2024Allow3010YesNo
17523672ADJUNCT MATERIALS AND METHODS OF USING SAME IN SURGICAL METHODS FOR TISSUE SEALINGNovember 2021November 2023Allow2410YesNo
17454408ADJUSTABLE ALL-SUTURE ANCHORING ASSEMBLY AND METHODNovember 2021August 2023Allow2210YesNo
17523664ADJUNCT MATERIALS AND METHODS OF USING SAME IN SURGICAL METHODS FOR TISSUE SEALINGNovember 2021June 2024Allow3101YesNo
17523657ADJUNCT MATERIALS AND METHODS OF USING SAME IN SURGICAL METHODS FOR TISSUE SEALINGNovember 2021May 2024Allow3110YesNo
17516124SUTURE RELEASE CONSTRUCTS AND METHODS OF TISSUE FIXATIONNovember 2021February 2024Allow2731YesNo
17509480PRE-FORMED SURGICAL KNOT LOADING SYSTEMS AND METHODS OF USEOctober 2021January 2025Abandon3911YesNo
17600733ULTRASONIC WAVEGUIDE AND BLADE FOR ULTRASONIC SURGICAL INSTRUMENTS AND METHOD OF MANUFACTURING THE SAMEOctober 2021November 2024Abandon3810NoNo
17484608KNOTLESS INSTABILITY ANCHORSeptember 2021January 2024Allow2800YesNo
17480385TRANSSEPTAL ACCESS DEVICE AND METHOD OF USESeptember 2021July 2022Allow1021YesNo
17474310TEETHING SYSTEMSeptember 2021May 2023Allow2000YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SHI, KATHERINE MENGLIN.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
0
(0.0%)
Examiner Reversed
1
(100.0%)
Reversal Percentile
99.3%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
7
Allowed After Appeal Filing
1
(14.3%)
Not Allowed After Appeal Filing
6
(85.7%)
Filing Benefit Percentile
15.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 14.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner SHI, KATHERINE MENGLIN - Prosecution Strategy Guide

Executive Summary

Examiner SHI, KATHERINE MENGLIN works in Art Unit 3771 and has examined 461 patent applications in our dataset. With an allowance rate of 87.4%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 30 months.

Allowance Patterns

Examiner SHI, KATHERINE MENGLIN's allowance rate of 87.4% places them in the 62% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by SHI, KATHERINE MENGLIN receive 1.32 office actions before reaching final disposition. This places the examiner in the 26% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SHI, KATHERINE MENGLIN is 30 months. This places the examiner in the 44% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +20.4% benefit to allowance rate for applications examined by SHI, KATHERINE MENGLIN. This interview benefit is in the 68% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 35.3% of applications are subsequently allowed. This success rate is in the 74% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 56.7% of cases where such amendments are filed. This entry rate is in the 79% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 83.3% of appeals filed. This is in the 75% percentile among all examiners. Of these withdrawals, 60.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 44.4% are granted (fully or in part). This grant rate is in the 49% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 42% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.0% of allowed cases (in the 65% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.